[1] Takagi S, Tsuji T, Amagai T, et al. Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies [J]. Developmental Biology, 1987, 122(1):90–100.[2] Luo Y,Raible D,Raper JA, et al.Collapsin:a protein in brain that induces the collapse and paralysis of neuronal growth cones[J].Cell,1993.75(2):p.217-27.[3] He Z,Tessier-Lavigne M.Neuropilin is a receptor for the axonal chemorepellent Semaphorin III[J].Cell,1997.90(4):p.739-51.[4] Wang L,Zeng H,Wang P,et al.Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration[J].J Biol Chem,2003.278(49):p.48848-60.[5] Whitaker GB,Limberg BJ,Rosenbaum JS.Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121) [J].J Biol Chem,2001.276(27):p.25520-31.[6] Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors.[J]. Faseb Journal, 1999, 13:9-22.[7] Vanveldhuizen PJ, Zulfigar M, Banerjee S, et al. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue[J]. Oncol Rep, 2003. 10(5): p. 1067-71.[8] Bielenberg DR, Pettaway CA, Takashima S, et al. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res[J]. 2006. 312(5): p. 584-93.[9] Ellis LM. The role of neuropilins in cancer[J]. Mol Cancer Ther, 2006. 5(5): p. 1099-107.[10] Stephenson JM, Banerjee S, Saxena NK, et al. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer[J]. Int J Cancer. 2002; 101(5):409-14.[11] Staton C, Kumar I, Reed M, et al. Neuropilins in physiological and pathological angiogenesis[J]. J Pathol. 2007; 212(3): 237-48.[12] Ochiumi T, Kitadai Y, Tanaka S, et al. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer[J]. Int J Oncol. 2006; 29(1): 105-16.[13] Starzec A, Ladam P, Vassy R, et al. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex[J]. Peptides, 2007. 28(12): p. 2397-402.[14] Duband JL, Monier F, Delannet M, et al.Newgreen D. Epithelium-mesenchyme transition during neural crest development[J]. Acta Anatomica. 1995;154(1):63–78.[15] Bolender DL, Markwald RR. Epithelial-mesenchymal transformation in chick atrioventricular cushion morphogenesis[J]. Scan Electron Microsc, 1979, 3:313-321. [16] Griffith CM, Hay ED. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels[J]. Development.1992;116(4):1087–1099. [17] Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion[J]. Cancer and Metastasis Reviews. 2009;28(1-2):15–33.[18] Cao Y, Wang L, Nandy D, et al. Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes[J]. Cancer Res, 2008. 68(21): p. 8667-72.[19] 张阳,傅振,宋晓萌,等. Semaphorin3A及其受体在舌鳞癌中的表达及作用[J]. 口腔生物医学,2011, 02(1):21—25[20] Wang ZL, Tang ZC, Zhang Y, et al. Neuropilin-1 down-regulation impairs cell migration and induces the differentiation of human tongue squamous cell carcinoma cells.[J]. Head Neck Oncol, 2012, 4: 54.[21] Zhang Y, He X, Liu Y, et al. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer[J]. Oncol Rep. 2012; 27(3): 685-94.[22] Mak P, Leav I, Pursell B, et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.[J]. Cancer Cell, 2010, 17(4):319-332. |